Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 809 results for "avp research"

Buy Poly Medicure, says Sandeep Raina

Sandeep Raina, AVP at Edelweiss RCM Research recommends buying Poly Medicure with a view of more than one and half years. Money Control, 2 weeks ago
V-Mart Retail good buy, says Sandeep Raina Money Control, 2 weeks ago
Here are Sandeep Raina's top trading ideas Money Control, 2 weeks ago

13 images for avp research

Starmometer, 1 week ago
Mideast Time, 3 weeks ago
American Banking News, 3 weeks ago
Silicon India, 1 month ago
Mideast Time, 1 month ago
American Banking News, 1 month ago
Mideast Time, 4 months ago
American Banking News, 4 months ago
American Banking News, 4 months ago
Mideast Time, 5 months ago

Buy silver natural gas; sell zinc: Navneet Damani

Watch the interview of Navneet Damani, AVP Commodities Currency Research at Motilal Oswal Commodities with Ekta Batra and Reema Tendulkar on CNBC-TV18. He spoke about the current trend in commodities markets.
 Money Control1 month ago

Hindalco underperformance due to interest cost rise: IIFL

Reacting to the Hindalco numbers, Tarang Bhanushali, AVP- Research, IIFL says the underperformance is largely due to a jump in interest cost which has come due to commissioning of new capacities during the quarter.
 Money Control1 month ago

Avon Products Receives BBB- Credit Rating from Morningstar (AVP)

Avon Products (NYSE:AVP) has received a "BBB-" credit rating from Morningstar. The research firm's "BBB-" rating indicates that the company is a moderate default risk. They also gave their stock a four star rating. Other equities research analysts ...
 American Banking News2 days ago Avon Products Given BBB- Credit Rating (AVP)  Mideast Time3 weeks ago Morningstar Gives BBB- Credit Rating to Avon Products (AVP)  American Banking News4 weeks ago Avon Products Given Consensus Recommendation of Hold by Brokerages (NYSE:AVP)  American Banking News4 weeks ago

Avon Products Rating Increased to Buy at BTIG Research (AVP)

Several other analysts have also recently commented on the stock. Analysts at Zacks reiterated a neutral rating on shares of Avon Products in a research note on Wednesday, August 27th. They now have a $15.00 price target on the stock. Separately, ...
 American Banking News3 weeks ago CFO Departure Could Further Delay Turnaround For Avon Products  Trefis1 week ago Avon Products Downgraded by Citigroup Inc. (AVP)  American Banking News1 week ago Stock Traders Purchase Large Volume of Avon Products Put Options (AVP)  American Banking News5 days ago
American Banking News

Research Analysts Upgrades for September, 9th (AVP, BKNIY, DEO, FBC, FNV, KLKNF, MRO, TOT, TRGP, UL)

Research Analysts upgrades for Tuesday, September 9th: KLOECKNER & CO
 American Banking News3 weeks ago
American Banking News

Research Analysts Ratings Reiterations for August, 27th (ABM, ADI, AEE, AGU, AVP, C, CBSH, COO, CZZ, DF)

Research Analysts ratings reiterations for Wednesday, August 27th: ABM Industries (NYSE:ABM) Analog Devices (NYSE:ADI) Ameren Corp (NYSE:AEE) Agrium (NYSE:AGU) Avon Products (NYSE:AVP) Citigroup (NYSE:C) Commerce Bancshares ...
 American Banking News1 month ago

Avon Products (AVP) Loses Momentum, Hits 52-Week low

Shares of Avon Products Inc. ( AVP ) have lost much of its momentum and yesterday this New York-based global beauty retailer stock hit a new 52-week low of $12.45. We believe that the recently announced resignation of the company's Chief Financial ...
 Yahoo! Finance1 day ago Avon Products Sets New 52-Week Low at $12.50 (AVP)  American Banking News5 days ago All Pop And No Sizzle Or Is Avanir Going Higher From Here?  Seeking Alpha2 weeks ago

Ad: Maels 2014, 16th October 2014, Le Meridien, New Delhi

This is an advertisement An aggressive industry research that Lex Witness conducted within the various stakeholders of the industry reflects a lot of ambiguity in the understanding of the current legal & regulatory regime. The 3rd Annual Edition ...
 Media Nama1 week ago
Pharma Letter

Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease

By a News Reporter-Staff News Editor at Biotech Week -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) announced positive results from its phase II clinical trial evaluating the safety and efficacy of AVP-923 for the treatment of agitation in patients ...
 HispanicBusiness.com1 week ago Avanir shares jump 85% on positive AVP-923 clinical trial results  Pharma Letter2 weeks ago Alzheimer's Study Results Take Avanir Back Up to Multiyear Highs  24/7 Wall St2 weeks ago Concert Pharmaceuticals Achieves $2 Million Milestone for AVP-786 Under Avanir Pharmaceuticals Collaboration  Pharmacy Choice3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less